Indole-3-Lactic Acid for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Indole-3-Lactic Acid for Health & Longevity

Created on 09/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Indole-3-lactic acid is a compound gut bacteria make from a dietary amino acid, studied for calming inflammation and slowing ageing. It is sold only as laboratory material, not for human use, so it is raised indirectly through those bacteria. In people it has almost always been measured rather than given; the findings point in more than one direction, and its effect in healthy adults is unmeasured. (Full Review)

Protocol

Infant-type bifidobacteria route
Bifidobacterium longum subsp. infantis, 8 × 10⁹ colony-forming units daily
Dose used in the trials that raised fecal concentrations
Adult fermented-milk route
Bifidobacterium longum BB536 in fermented milk
Raised fecal concentrations in healthy adults within 17 days
Competing approach — prebiotic first
Fibre-led regimen, no organism introduced
Lowers colonic pH and frees tryptophan from competing indole producers
Time to effect
Fecal concentrations
Days to weeks
Significant increases by day 17 in a healthy-adult trial
Clinical benefit
No figure exists
No human clinical outcome has been measured
After stopping
Within weeks
Fecal concentrations fall back toward baseline; colonisation is transient

Benefits

Contraindications
  • Anti-PD-1 checkpoint immunotherapy (particularly esophageal squamous cell carcinoma)
  • Chronic kidney disease stage 4 or 5 (filtration below 30 mL/min/1.73 m²) or dialysis
  • Pregnancy and breastfeeding
  • Preterm and term neonates outside a supervised trial
  • Central venous catheter, severe immunosuppression or short bowel syndrome
    •
Key Interactions
  • Broad-spectrum antibiotics (amoxicillin-clavulanate, ciprofloxacin, clindamycin): sharp fall in production
  • Proton pump inhibitors and antacids (omeprazole, esomeprazole, calcium carbonate): shift toward indoxyl sulfate
  • Tryptophan and 5-HTP supplements: increased output of all downstream indoles
  • Statins (atorvastatin, rosuvastatin, simvastatin): additive, generally favourable
  • Probiotics carrying the producing enzyme (Bifidobacterium longum, Bifidobacterium breve, Lactiplantibacillus plantarum): additive and intended
  • Prebiotic fibres (inulin, galacto-oligosaccharides, beta-glucan, resistant starch): higher output
  • Fecal microbiota transplantation, exercise training: higher circulating concentrations
    •

Risk & Side Effects

  • High:
  • Medium: Higher circulating levels track cardiovascular events and death; reduced response to cancer immunotherapy (conflicted); elevated newborn levels linked to later attention deficits
    •
  • Low: Accumulation when kidney filtration falls
    •
  • Speculative: Immune dampening from sustained receptor activation; central nervous system exposure and appetite effects; unknown consequences in pregnancy
    •

Monitoring

Marker Target Why
Plasma indole-3-lactic acid No established target; track change from own baseline Direct measure of systemic exposure
Fecal indole-3-lactic acid No established target; track change from own baseline Reflects colonic production rather than systemic exposure
hs-CRP Below 0.5 mg/L Tracks the low-grade inflammation the compound is proposed to lower
eGFR (cystatin C based) Above 90 mL/min/1.73 m² Falling filtration raises blood concentrations independently of production
Fecal calprotectin Below 50 µg/g Objective marker of intestinal inflammation, the best-supported target
Stool Bifidobacterium relative abundance No established adult target; track change from own baseline Indicates whether the producing organisms are actually present
Serum tryptophan 45–75 µmol/L Substrate availability for the whole pathway

Cadence: Kidney filtration and inflammation markers at 3 months, then every 6–12 months; the metabolite and stool composition at 3 months and again at 12 months

Qualitative Assessment

  • Stool form and frequency, which respond to fermentable fibre before any metabolite shift is detectable
  • Abdominal bloating and gas, which indicate whether fibre was introduced too quickly
  • Energy levels through the afternoon, a non-specific but sensitive marker of gut-related inflammation
  • Cognitive clarity and mood stability, the domains where the animal work is most active and human data most absent
  • Skin comfort and barrier behaviour, given that resident skin bacteria produce the same compound
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.